Cardlytics Inc (CDLX) stock expected to rise by 61.84%: What’s driving the optimism?

A share price of Cardlytics Inc [CDLX] is currently trading at $4.14, up 3.76%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CDLX shares have gain 8.09% over the last week, with a monthly amount glided 33.12%, and seem to be holding up well over a long-time horizon.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

From an analyst’s perspective:

Cardlytics Inc [NASDAQ: CDLX] stock has seen the most recent analyst activity on October 11, 2024, when Evercore ISI initiated its In-line rating and assigned the stock a price target of $4. Previously, Northland Capital downgraded its rating to Market Perform on August 16, 2024, and kept the price target unchanged to $5. On August 15, 2024, downgrade downgraded it’s rating to Underperform and revised its price target to $3.50 on the stock. Needham downgraded its rating to a Hold. Lake Street downgraded its rating to a Hold and reduced its price target to $5 on August 08, 2024. Craig Hallum downgraded its rating to Hold for this stock on August 08, 2024.

Cardlytics Inc experienced fluctuations in its stock price throughout the past year between $2.89 and $20.52. Currently, Wall Street analysts expect the stock to reach $6.7 within the next 12 months. Cardlytics Inc [NASDAQ: CDLX] shares were valued at $4.14 at the most recent close of the market. An investor can expect a potential return of 61.84% based on the average CDLX price forecast.

Analyzing the CDLX fundamentals

Trailing Twelve Months sales for Cardlytics Inc [NASDAQ:CDLX] were 305.42M which represents -9.21% decline. Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at -0.22%, Pretax Profit Margin comes in at -0.5%, and Net Profit Margin reading is -0.5%. To continue investigating profitability, this company’s Return on Assets is posted at -0.29, Equity is -0.8 and Total Capital is -0.16. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of1.02.

Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 3.99 points at the first support level, and at 3.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 4.31, and for the 2nd resistance point, it is at 4.47.

Ratios To Look Out For

To put it in perspective, the Current Ratio for Cardlytics Inc [NASDAQ:CDLX] is 1.77. Also, the Quick Ratio is 1.77, while the Cash Ratio stands at 0.68. Considering the valuation of this stock, the price to sales ratio is 0.68, the price to book ratio is 0.97.

Transactions by insiders

Recent insider trading involved Gupta Amit, Chief Executive Officer, that happened on Oct 24 ’24 when 22607.0 shares were sold. Officer, Gupta Amit completed a deal on Oct 24 ’24 to buy 22607.0 shares. Meanwhile, Chief Financial Officer DeSieno Alexis sold 7487.0 shares on Oct 02 ’24.

Related Posts